StockMarketWire.com - JP Morgan Cazenove today reaffirms its overweight investment rating on Circassia Pharmaceuticals Plc Ord 0.08p [LON:CIR] and raised its price target to 410p (from 390p).

Story provided by StockMarketWire.com